Centessa Pharmaceuticals plc ADR (CNTA) Stock: Navigating Drops and Gains

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Centessa Pharmaceuticals plc ADR’s current trading price is -21.37% away from its 52-week high, while its distance from the 52-week low is 90.10%. The stock’s price range for this time frame has been between $5.15 and $12.45. The trading volume of the company’s shares in the Healthcare reached around 0.5 million for the day, which was evidently higher than the average daily volume of 0.22 million over the last three months.

The market performance of Centessa Pharmaceuticals plc ADR has been somewhat stable. Over the past year, the company’s stock achieved a high of $12.45 on 03/22/24, with the lowest value for the same timeframe being $5.15, recorded on 10/03/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

How Financial Performance Impacts Market Capitalization

Centessa Pharmaceuticals plc ADR (CNTA) has experienced a quarterly decline of -8.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 983.70M and boasts a workforce of 76 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 9.92, with a change in price of +0.29. Similarly, Centessa Pharmaceuticals plc ADR recorded 249,327 in trading volume during the last 100 days, posting a change of +3.05%.

How CNTA’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CNTA stands at 0.40. Similarly, the long-term debt-to-equity ratio is also 0.40.

CNTA Stock Stochastic Average

The raw stochastic average for Centessa Pharmaceuticals plc ADR over the last 50 days is presently at 81.93%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 74.72%. Further, the company’s Stochastic %K and %D values for the last 20 days were 40.64% and 25.49%, respectively.

CNTA Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 22.99% this year. Over the last six months, there has been a weaker performance of 45.47%. The price of CNTA fallen by 9.75% during the last 30 days period. For the last 5-days stocks have improved 11.25%.

Most Popular